期刊文献+

异氟醚预处理对心肺转流冠状动脉搭桥手术患者的心肌保护作用 被引量:1

Myocardial protective effects of isoflurane preconditioning during CABG under cardiopulmonary bypass
原文传递
导出
摘要 目的观察异氟醚预处理对心肺转流(CPB)冠状动脉搭桥手术(CABG)患者心肌的保护作用。方法 CABG患者20例,随机均分为异氟醚预处理组(A组,CPB开始前持续吸入1.5MAC异氟醚10min,然后洗脱10min)和对照组(B组,不行异氟醚预处理),分别于麻醉后(T1)、主动脉开放后15min(T2)、CPB结束后2h(T3)和24h(T4)检测血清降钙素基因相关肽(CGRP)、血管内皮素(ET)和心肌钙蛋白(cTnI)。结果 T2、T3和T4时,两组CGRP明显高于T1(P<0.01),但T2、T3时A组高于B组(P<0.05);T2、T3时,两组ET均明显高于T1(P<0.01),但A组低于B组(P<0.05);T2、T3和T4时,两组cTnI均高于T1(P<0.01),但T3和T4时,A组明显低于B组(P<0.01)。结论异氟醚预处理能减少心肌的缺血-再灌注损伤。 Objective To investigate the myocardial protective effects of isoflurane preconditioning during coronary artery bypass grafting(CABG) under cardiopulmonary bypass(CPB). Methods Twenty CABG patients under CPB were equally randomized into two groups of A (1.5 MAC isoflurane inhalation for 10 rain and washing out for 10 min before CBP) and B(without isoflurane inhalation). Blood samples were taken for the measurements of Calcitonin gene-related peptide(CGRP), endothelin (ET) and calcitonin-I (cTnI) after anesthesia induction (T1), at 15 rain after aorta unclamping(T2), 2 h(T3) and 24 h(T4) after CPB. Results Compared to T1, serum CGRP levels o[ both groups were increased at T2,T3 and T4(P〈0. 01) ,which at T2 and T3 were higher in group A than those in group B(P〈0. 05). Compared to T1, serum ET levels of both groups were increased at T2 and T3 (P〈0. 01),which were lower in group A than those in group B(P〈0. 05). Compared to T1, serum cTnI levels of both groups were increased at T2,T3 and T4(P〈0. 01), which at T3 and T4 were lower in group A than those in group B (P〈0. 01 ). Conclusion Isoflurane preconditioning can protect the myocardium against ischemia-reperfusion jury in CABC under CPB.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第24期2961-2963,共3页 Jiangsu Medical Journal
关键词 异氟醚预处理 心肺转流 血清降钙素基因相关肽 血管内皮素 心肌钙蛋白 Isoflurane preconditioning Cardiopulmonary bypass Calcitonin gene-related peptide Endothelin Calcitonin-I
  • 相关文献

参考文献11

  • 1Kehl F, Krolikowski JG, Mraovic B, et al. Is isoflurane-induced preconditioning dose related [J]? Anesthesiology, 2002, 96 (3) : 675-680.
  • 2Mtillenheim J, Ebel D, Frassdorf J, et al. Isoflurane precondi- tioning myocardium against infarction via release of free radicals[J]. Anesthesiology, 2002,96 (4) : 934-940.
  • 3Awad WI,Shattock MJ,Chamber DJ. Ischemic preconditioning in immature myocardium[J]. Cirulation, 1998, 98 ( 19 Suppl) : 206-213.
  • 4Banz Y, Rieben R. Role of complement and perspectives for intervention in ischemia-reperfusion damage[J]. Ann Med, 2012,44(3) :205-217.
  • 5Kwok WM, Martinelli AT, Fujimoto K, et al. Differential modulation of the cardiac adenosine triphosphate-sensitive potassium channel by isoflurane and halothane [J]. Anesthesiology, 2002,97 (1) : 50-56.
  • 6Zvara DA, Bryant AJ, Deal DD, et al. Anesthetic precondi- tioning with sevoflurane does not protect the spinal cord after an ischemia-reperfusion injury in the rat[J]. Anesth Analg, 2006,102(5) : 1341-1347.
  • 7Peng CF, Li YJ, Deng HW, et al. The protective effects of ischemic and calciton in gene-related peptide-indueed preconditioning on myocardial injury by endothelin-1 in the isolated perfused rat heart[J]. Life Sci, 1996,59 (18) : 1507- 1514.
  • 8Ezra D, Laurindo FR, Goldstein DS, et al. Calcitonin gene- related peptide: a potent modulator of coronary flow[J]. Eur J Pharmacol, 1987,137(1) : 101-105.
  • 9Bell D, Schltiter KD, Zhou XJ, et al. Hypertrophic effects of calcitonin gene-related peptide(CGRP) and amylin on adult mammalian ventricular cardiomyocytes [ J ]. J Mol Cell Cardiol, 1995,27(11) : 2433-2443.
  • 10Adams JE 3rd, Bodor GS, Davila-Ronan VG, et al. Cardiac troponin I. A marker with high specificity for cardiac injury[J]. Circulation, 1993,88(1) : 101-106.

二级参考文献8

  • 1关启刚,曾定尹,孙喜琢,苗志林,周旭晨,何学志,韩凤桐,程颖,张利.Rho激酶在小型猪白介素-1β介导的冠状动脉痉挛中的作用机制[J].中华心血管病杂志,2006,34(1):50-53. 被引量:19
  • 2Mohri M, Shimokawa H, Hirakawa Y, et al. Rho-kinase inhibition with intraeoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm [J]. J Am Coll Cardiol, 2007, 41(1) :15-19.
  • 3Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine [ J]. Arterioscler Thromb Vasc Biol, 2005,25(9) :1767-1775.
  • 4Noma K, Oyama N, Liao JK. Physiological role of ROCKs in the cardiovascular system [ J ]. Am J Physiol Cell Physiol, 2006,290 (3) :C661-668.
  • 5Vincelette J, Pagila R, Kawai K, et al. Inhibition of rho-kinase by hydroxyfasudil prevents vasopressin-induced myocardial ischemia in Donryu rats by attenuating coronary vasoconstriction [ J ]. pharmacology, 2005,75 ( 3 ) : 145-151.
  • 6Hiroki J, Shimokawa H, Higashi M, et al. Inflammatory stimuli upregulate Rho-kinase in human vascular smooth muscle [ J ]. J Mol Cell Cardiol, 2004,37(2) :537-546.
  • 7Song J, Li J, Lulla A, et al. Protein kinase D protects against oxidative stress-induced intestinal epithelial cell injury via Rho/ROK/ PKC-deha pathway activation [ J ]. Am J Physiol Cell Physiol, 2006,290(6) :C1469-1476.
  • 8Li J, OConnor KL, Hellmieh MR, et al. The role of protein kinase D in neurotensin secretion mediated by protein kinase C-alpha/-delta and Rho/Rho kinase [ J]. J Biol Chem, 2004,279 (27) :28466- 28474.

共引文献6

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部